Inflammation Markers in Hyperemesis Gravidarum

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

215 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-01-20

Study Completion Date

2022-06-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the relationship between the severity of hyperemesis gravidarum (HEG) disease and subclinical inflammatory factors such as Platelet Crit (PCT), Hemoglobin/red cell distribution width ratio (HRR), Neutrophil/lymphocyte ratio (NLR), was investigated.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of neutrophil-to Lymphocyte Ratio in Preeclampsia- Eclampsia

NCT01856387

Preeclampsia Eclampsia

UNKNOWN

Perinatal Outcomes and Hematologic Parameters in COVID-19 Pregnancies

NCT04515108

Pregnancy, Infections in Covid19

COMPLETED

Endothelial Dysfunction in Hyperemesis Gravidarum

NCT02989337

Hyperemesis; Gravidarum, With Dehydration

UNKNOWN

Maternal Serum Markers Predicting Preeclampsia At Early Gestations

NCT05131282

Pre-eclampsia Preterm Birth

COMPLETED

The Levels of the Orexin, Galanin and aMSH and CART in Patients With Hyperemesis Gravidarum

NCT05446025

Hyperemesis Gravidarum Pregnancy Related

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A total of 215 pregnant women, 102 with hyperemesis gravidarum and 113 healthy pregnant women, were included in the study. HEG patients were divided into three groups according to the modified PUQE classification: mild (n=38), moderate (n=32) and severe (n=32).

In our study, we proposed using a new prognostic marker for HEG patients. We think that our study will be a source for future studies on HEG.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hyperemesis Gravidarum

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy pregnant women over 18 years of age
* 5-16 weeks of gestation.

Exclusion Criteria

Smoking, urinary tract infections, previously diagnosed psychological disorders, gastrointestinal disorders, multiple pregnancies, eating disorders, thyroid disorders, inflammatory disease, pregnancy with assisted fertilization technique.

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No